Literature DB >> 8886402

Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.

X J Yu1, M A Moskowitz.   

Abstract

1. The effects of neuropeptide Y (NPY) receptor agonists (administered intravenously) were examined on plasma protein ([125I]-bovine serum albumin) leakage within dura mater evoked by unilateral trigeminal ganglion stimulation (0.6 mA, 5 ms, 5 Hz, 5 min), capsaicin (1 mumol kg-1, i.v.) or substance P (1 nmol kg-1, i.v.) in anaesthetized Sprague-Dawley rats. 2. NPY (EC50: 5.6 nmol kg-1) and NPY fragment 13-36 [NPY (13-36)] (ED50: 4.3 nmol kg-1), an NPY Y2 receptor agonist, dose-dependently attenuated [125I]-bovine serum albumin extravasation from meningeal vessels when administered 10 min prior to electrical stimulation. [Leu31, Pro34]-NPY, an NPY Y1 and Y3 receptor agonist, inhibited the response at a higher dose only (23 nmol kg-1) (P < 0.05). 3. NPY also significantly decreased plasma protein extravasation induced by capsaicin (1 mumol kg-1) but not by substance P (1 nmol kg-1). 4. Pertussis toxin (20 micrograms kg-1, administered intracisternally 48 h prior to stimulation) blocked completely the inhibitory effect of NPY and NPY (13-36) but did not inhibit extravasation alone. 5. We conclude that NPY inhibits neurogenically-mediated plasma protein extravasation acting through presynaptic pertussis toxin-sensitive NPY Y2 receptors, possibly by inhibition of neuropeptide release from perivascular trigeminovascular afferents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886402      PMCID: PMC1915851          DOI: 10.1111/j.1476-5381.1996.tb15975.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Intracerebroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y(13-36) in the awake unrestrained male rat.

Authors:  J A Narváez; J A Aguirre; I Van der Ploeg; K Fuxe
Journal:  Neurosci Lett       Date:  1992-06-22       Impact factor: 3.046

Review 2.  Neuropeptide Y effector systems: perspectives for drug development.

Authors:  L Grundemar; R Håkanson
Journal:  Trends Pharmacol Sci       Date:  1994-05       Impact factor: 14.819

3.  Some sensory neurons express neuropeptide Y receptors: potential paracrine inhibition of primary afferent nociceptors following peripheral nerve injury.

Authors:  P W Mantyh; C J Allen; S Rogers; E DeMaster; J R Ghilardi; T Mosconi; L Kruger; P J Mannon; I L Taylor; S R Vigna
Journal:  J Neurosci       Date:  1994-06       Impact factor: 6.167

4.  Neuropeptide Y inhibits neurogenic inflammation in guinea pig airways.

Authors:  T Takahashi; M Ichinose; H Yamauchi; M Miura; N Nakajima; J Ishikawa; H Inoue; T Takishima; K Shirato
Journal:  J Appl Physiol (1985)       Date:  1993-07

5.  Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms.

Authors:  S A Wager-Pagé; E Raizada; W Veale; J S Davison
Journal:  Can J Physiol Pharmacol       Date:  1993 Oct-Nov       Impact factor: 2.273

Review 6.  Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine.

Authors:  M A Moskowitz
Journal:  Trends Pharmacol Sci       Date:  1992-08       Impact factor: 14.819

7.  Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation.

Authors:  W S Lee; V Limmroth; C Ayata; F M Cutrer; C Waeber; X Yu; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain.

Authors:  S Markowitz; K Saito; M A Moskowitz
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

9.  Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.

Authors:  F M Cutrer; D Schoenfeld; V Limmroth; N Panahian; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  The neurobiology of vascular head pain.

Authors:  M A Moskowitz
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

View more
  1 in total

1.  Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine.

Authors:  Margarida-Martins Oliveira; Simon Akerman; Isaura Tavares; Peter J Goadsby
Journal:  Pain       Date:  2016-08       Impact factor: 7.926

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.